Q4 2020 Holdings
Filed 2021-02-16 | 19 holdings | $54.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atea Pharmaceuticals(AVIR) | Common Stock | 04683R106 | $35.4M | 847,208 | 65.5% |
| Arcutis Biothereapeutics(ARQT) | Common Stock | 03969K108 | $18.0M | 640,199 | 33.3% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $193.6K | 5,074,783 | 0.4% |
| Kronos Bio(KRON1USD) | Common Stock | 50107A104 | $114.1K | 3,818,283 | 0.2% |
| Morphic Holding | Common Stock | 61775R105 | $98.0K | 2,921,771 | 0.2% |
| Spruce Biosciences | Common Stock | 85209E109 | $52.5K | 2,161,022 | 0.1% |
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $32.1K | 3,320,608 | 0.1% |
| Immunic(IMUX) | Common Stock | 4525EP101 | $27.3K | 1,788,160 | 0.1% |
| Checkmate Pharmaceuticals | Common Stock | 162818108 | $19.5K | 1,335,050 | 0.0% |
| Syros Pharmaceuticals | Common Stock | 87184Q107 | $17.0K | 1,562,500 | 0.0% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $16.3K | 2,600,410 | 0.0% |
| Alpine Immune Sciences(NVLSEUR) | Common Stock | 02083G100 | $16.2K | 1,284,900 | 0.0% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $8.4K | 705,693 | 0.0% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $4.8K | 130,646 | 0.0% |
| Cidara Therapeutics | Common Stock | 171757107 | $4.0K | 2,005,249 | 0.0% |
| Trevi Therapeutics(TRVI) | Common Stock | 89532M101 | $3.3K | 1,263,408 | 0.0% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $2.3K | 334,965 | 0.0% |
| ObsEva | Common Stock | H5861P103 | $2.1K | 999,364 | 0.0% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $1.9K | 750,741 | 0.0% |